Aethlon Medical (AEMD) Misses Q4 EPS by 45c

Aethlon Medical (NASDAQ: AEMD) reported Q4 EPS of ($0.65), $0.45 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $659 thousand versus the consensus estimate of $370 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ennis (EBF) Reports In-Line Q1 EPS
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)